Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Battaglia

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|March 22, 2013
Mobilomics in Saccharomyces cerevisiae strainsGiulia Menconi, Giovanni Battaglia, Roberto Grossi, et al.
Journal of the American Society of Nephrology : JASN|September 4, 2010
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRDFrancesco Locatelli, Paolo Altieri, Simeone Andrulli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|March 22, 2013
Mobilomics in Saccharomyces cerevisiae strainsGiulia Menconi, Giovanni Battaglia, Roberto Grossi, et al.
Journal of the American Society of Nephrology : JASN|September 4, 2010
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRDFrancesco Locatelli, Paolo Altieri, Simeone Andrulli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Pageof 1